Hydrosurgery Systems Sales Expand amid Heightening Chronic and Traumatic Injury Episodes: Fact.MR

Prevalence of diabetic foot ulcers and surging cases of burn induced traumatic injuries to facilitate enhanced deployment of advanced and minimally invasive surgical procedures

Fact.MR, Rockville: Award winning market research company Fact.MR’s report on the global hydrosurgery system market projects a steady growth path for FY 2021-22, with long-term growth prospects remain optimistic, registering a noteworthy CAGR. Growth is largely underpinned by the increasing frequency of chronic and traumatic wounds in recent years.  

According to the World Health Organization, an estimated 25,000 deaths occur annually as a result of fires alone, while deaths due to scalds and electrical burns adding to the list. Over 96% of fatal burns occur in low and middle income countries, while million are left with lifetime disabilities and disfigurements. Hence, efforts to escalate preventable surgeries have increased, providing a wide ground for the expansion of hydrosurgery systems in the future.

Likewise, it is anticipated that at least 1 to 2% of the population across developed countries are likely to experience at least one chronic wound during their lifetime. For instance, in the United States, over 6 million patients suffer from chronic wounds while in Scandinavia, associated costs constitute 2-4% of total healthcare expenditures. All these developments are attracting prominent manufacturers to deepen their penetration across lucrative markets.

“As the global geriatric population expands, the demand for treating debilitating conditions is anticipated to bolster the need for minimally invasive surgical procedures to reduce trauma. Hence, manufacturers are deploying a host of differently modelled hydrosurgery systems,” remarks the Fact.MR analyst.

Request a report sample of 170 pages to gain insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4706

Key Takeaways from the Hydrosurgery Systems Study

• By component type, handpiece systems to remain most preferred, owing to easy maneuverability
• Chronic wound treatment likely to emerge as a key application area due to high prevalence rate of various conditions
• Demand for homecare settings based hydrosurgery systems to surge as preference for personalized treatment expands
• U.S to capture an attractive market share, given the high diagnosis rate of chronic conditions such as diabetes and consequent increase in chronic wounds
• Proliferating technological advancements in medical research to fuel the U.K market
• Germany and France to experience stable growth, attributed to the proliferation of regional level manufacturers
• Asia-Pacific to emerge as the kingpin: China and India to pivot growth

Hydrosurgery Systems Market- Prominent Drivers

• High demand for precision-based surgery to fuel technological advancements, fueling hydrosurgery systems sales
• Rising incidence of chronic wounds due to increased cases of conditions such as obesity and diabetes to augment adoption of hydrosurgery systems to treat the same
• Manufacturers are also increasingly deploying hydrosurgery systems for traumatic wounds, leading to further broadening of revenue margins

Discover more about the hydrosurgery systems market with 83 figures and 49data tables, along with the table of contents. You will also find detailed market segmentation on https://www.factmr.com/report/4706/hydrosurgery-systems-market

Competitive Landscape

Prominent players associated with the manufacturing of hydrosurgery devices include, but are not limited to, HydroCision, Smith & Nephew Plc., Erbe Elektromedizin GmbH and others. New product offerings equipped with the most contemporary technological advancements is the primary strategy deployed by these players to retain their footprint.

Smith & Nephew Plc. is a highly influential player, marketing the VERSAJET II Hydrosurgery System, equipped to enhance preservation of viable tissue during surgical debridement. It also reduces time to closure as well as streamlining excision through procedural efficiency. The system facilitates easy removal of bacteria, preventing the risk of infection.

In 2018, HyrdoCision entered into a distribution agreement with Konica Minolta Healthcare Americas Inc. Under this agreement, the latter became an authorized distributor of the former’s TenJet Percutaneous Tenotomy System for minimally invasive tenotomy procedures. In 2019, the company announced a licensing agreement with PROCEPT BioRobotics to provide access to its pump cartridge technology for Urological procedures.

More Insights on the Hydrosurgery Systems Market

The research study on Hydrosurgery Systems market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends, which have shaped the landscape of Hydrosurgery Systems over 2014 – 2018 and includes a detailed assessment of key parameters that are anticipated to exert influence over 2019 – 2029. Market statistics have been presented on the basis of component type (system console, handpiece, accessories), and end user (hospitals, ASCs, specialized clinics and long-term care centers) across seven major regions.

Explore Fact.MR’s Coverage on the Healthcare Domain

Multiphoton Microscopy Market: Fact.MR recently published a market study on the global market for multiphoton microscopy. The study provides detailed assessment of the market background and market dynamics, including the drivers, trends, opportunities, restraints, and detailed information about the market structure. The market study presents exclusive information about how the multiphoton microscopy market will grow during the forecast period (2020-2030). 

Respiratory Virus Vaccines Market: A detailed study by Fact.MR on the respiratory virus vaccines market offers a 10-year forecast for 2020 and 2030. The study analyzes crucial trends that are currently determining the growth of the respiratory virus vaccines market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players.

Rare Neurodegenerative Disease Treatment Market: Fact.MR’s rare neurodegenerative disease treatment market research report gives a clear assessment of critical market dynamics, including the drivers, trends, opportunities, and restraints expected to prevail in the market for the upcoming decade. The market study presents exclusive information about how the rare neurodegenerative disease treatment market will grow during the forecast period of 2020-2030. 

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates